1Drake LA, Dinehart SM, Farmer ER, et al. Guidelines of care for androgenetic alopecia. American Academy of Dermatology. J Am Acad Dermatol, 1996,35:465 -469.
2Hoffmann R,Niiyama S, Huth A, et al. 17alpha-estradiol induces aromatase activity in intact human anagen hair follicles ex vivo. Exp Dermatol, 2002,11:376 - 380.
3Sovak M, Seligson AL, Kucerova R, et al. Fluridil, a rationally designed topical agent for androgenetic alopecia: first clinical experience. Dermatol Surg, 2002,28:678 -685.
4Otomo S. Hair growth effect of minoxidil. Nippon Yakurigaku Zasshi,2002,119:167 - 174.
5Vexiau P,Chaspoux C, Boudou P,et al. Effects of minoxidil 2% vs.cyproterone acetate treatment on female androgenetic alopecia: a controlled, 12 - month randomized trial. Br J Dermatol, 2002,146:992 -999.
7Sadick NS, Shea CR, Nicholson J, et al. A comparative clinical and histologic study of hair transplantation using Er: YAG, Er: YAG/CO2,and standard punch techniques. Dermatol Surg, 2001,27:807 -812.
8Sadick N. Elliptografting: the right fit. Dernatol Surg, 2001,27:739- 743.
9Finasteride Male Pattern Hair Loss Study Group. Long-term (5 -year) multinational experience with finasteride 1 mg in the treatment of men with androgenetic alopecia. Eur J Dermatol, 2002 ,12:38 -49.
10Avram MR, Cole JP, Gandelman M, et al. The potential role of minoxidil in the hair transplantation setting. Dermatol Surg, 2002,28:894 - 900.
